A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
Eligible for screening study DCP 001
BN011 is temporarily closed to accrual from 5 PM ET December 4, 2025, to January 26, 2026.
